Foxy-5 inhibits metastases
The purpose of WntResearch drug candidate Foxy-5 is to inhibit metastases, i.e. that a tumor spreads to other parts of the body. Foxy-5 is currently being evaluated in the Clinical Phase II study NeoFox.
”It is not the primary tumor that primarily kills the cancer patient, it is the metastases”
Professor Tommy Andersson, scientific advisor and founder of WntResearch
